Hello Friends! Are you looking to invest in the stock market, or have you already invested? Would you like to know the predictions regarding the potential fluctuations in your shares? If so, you have landed on exactly the right page. On this page, you will find information regarding Zydus Lifesciences buyback, Zydus lifesciences share price history, Zydus lifesciences share price screener, Zydus Lifesciences share price TradingView, Zydus Life share price NSE, Zydus Lifesciences share price target 2030, and much more. Furthermore, this page provides details on Zydus Lifesciences‘s share price targets 2026, 2027, 2028, 2029, 2030, 2040, and beyond.
Zydus Lifesciences Company Information
| Industry | Pharmaceuticals |
| Founded | 1952 (74 years ago) |
| Founder | Ramanbhai Patel |
| Headquarters | Ahmedabad, Gujarat, India |
| Number of employees | 27,917 (2025) |
| Key people | Pankaj R. Patel (Chairman) Sharvil P. Patel (Managing Director) |
Zydus Lifesciences Share Price Target Overview
- Current Price – 1,082.00
- Open – 1,096.45
- High – 1,115.50
- Low – 1,071.20
- Mkt cap – 1.09LCr
- P/E ratio – 21.60
- 52-wk high – 1,115.50
- 52-wk low – 835.50
- Dividend – 0.092%
- Qtrly div amt – 0.249
Zydus Lifesciences Share Price Chart
Zydus Lifesciences Share Price Target Tomorrow (Prediction)
| Zydus Lifesciences Share Price Target Years | Zydus Lifesciences Share Price Target |
| 2026 | ₹1030 |
| 2027 | ₹1180 |
| 2028 | ₹1340 |
| 2029 | ₹1500 |
| 2030 | ₹1650 |
Zydus Lifesciences Share Price Target 2026
The target for Zydus Lifesciences’s share price in 2026 is projected to range between ₹1000 and ₹1030. As of the end of May 2026, Zydus Lifesciences’s share price stood at ₹1,082.00. Compared to the previous year, Zydus Lifesciences’s share price has witnessed an decrease this year.
Zydus Lifesciences Share Price Target 2027
The target for Zydus Lifesciences’s share price in 2027 is projected to range between ₹1150 and ₹1180. On 30 May 2026, Zydus Lifesciences Share price NSE is 1,082.00 INR. Compared to last year, no significant difference has been observed in the share price of Zydus Lifesciences. The share price has decreased by approximately 150-160 rupees.
Zydus Lifesciences Share Price Target 2030
The target for Zydus Lifesciences’s share price in 2030 is projected to range between ₹1630 and ₹1650. Over the past several years, the company has generated substantial profits, and investors, too, have earned handsome returns proportionate to their shareholdings. We remain optimistic that the company will continue to generate profits in the future, thereby ensuring continued returns for its investors.
Read Also:- Blue Jet Healthcare Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Zydus Lifesciences Shareholding Pattern
| Promoter | 75% |
| FII | 6.95% |
| DII | 6.33% |
| Retails & Others | 6.86% |
| Mutual Funds | 4.88% |
Income Statement Of Zydus Lifesciences
|
All values in INR
|
Jun 2025
|
Sep 2025
|
Dec 2025
|
Mar 2026
|
|---|---|---|---|---|
|
Revenue
|
65.74B
|
61.23B
|
68.65B
|
75.87B
|
|
Cost of goods sold
|
17.90B
|
16.91B
|
18.36B
|
19.76B
|
|
Cost of revenue
|
17.90B
|
16.91B
|
18.36B
|
19.76B
|
|
Research and development expenses
|
–
|
–
|
–
|
–
|
|
Total research and development expenses
|
–
|
–
|
–
|
–
|
|
Selling, general, and admin expenses
|
10.05B
|
10.34B
|
11.40B
|
12.39B
|
|
Operating expense
|
29.91B
|
31.33B
|
37.36B
|
42.10B
|
|
Total operating expenses
|
47.80B
|
48.23B
|
55.72B
|
61.86B
|
|
Operating income
|
17.93B
|
13.00B
|
12.92B
|
14.01B
|
|
Other non operating income
|
1.55B
|
1.09B
|
1.11B
|
1.34B
|
|
EBT including unusual items
|
19.55B
|
16.93B
|
14.11B
|
16.59B
|
|
EBT excluding unusual items
|
19.55B
|
17.27B
|
14.96B
|
20.57B
|
|
Income tax expense
|
4.34B
|
4.54B
|
3.88B
|
3.18B
|
|
Effective tax rate
|
22.20%
|
26.82%
|
27.52%
|
19.19%
|
|
Other operating expenses
|
17.48B
|
17.97B
|
22.37B
|
24.62B
|
|
Net income
|
14.67B
|
12.59B
|
10.42B
|
12.73B
|
|
Net profit margin
|
22.31%
|
20.55%
|
15.18%
|
16.77%
|
|
Earnings per share
|
14.58
|
12.76
|
10.96
|
15.84
|
|
Interest and investment income
|
–
|
–
|
–
|
–
|
|
Interest expense
|
-847.00M
|
-1.01B
|
-1.30B
|
-1.23B
|
|
Net interest expenses
|
-847.00M
|
-1.01B
|
-1.30B
|
-1.23B
|
|
Depreciation and amortization charges
|
2.38B
|
3.02B
|
3.60B
|
5.08B
|
|
EBITDA
|
20.11B
|
15.70B
|
15.10B
|
17.69B
|
|
Gain or loss from assets sale
|
–
|
–
|
–
|
–
|
Read Also:- IFGL Refractories Share Price Target Tomorrow From 2026 to 2030 – Current Chart, Market Overview
Hi, I’m Ronak, a news writer covering the latest updates in automobiles, education, smartphones, and trending topics. I focus on delivering simple, clear, and timely news to keep readers informed about what’s happening around the world.